Author:
Tuncay Erkan,Zeydanli Esma N.,Turan Belma
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Ahmet I, Krawczyk M, Zhu W, Woo AY, Morrell C, Poosala S, Xiao RP, Lakatta EG, Talan MI (2008) Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction. J Pharmacol Exp Ther 325(2):491–499
2. Angeli F, Verdecchia P, Karthikeyan G, Mazzotta G, Gentile G, Reboldi G (2010) ß-blockers reduce mortality in patients undergoing high-risk non-cardiacsurgery. Am J Cardiovasc Drugs 10(4):247–259
3. Aydemir-Koksoy A, Bilginoglu A, Sariahmetoglu M, Schulz R, Turan B (2010) Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. J Nutr Biochem 21(9):827–833
4. Bidasee KR, Nallani K, Besch HR Jr, Dincer UD (2003) Streptozotocin-induced diabetes increases disulfide bond formation on cardiac ryanodine receptor (RyR2). J Pharmacol Exp Ther 305(3):989–998
5. Bilginoglu A, Seymen A, Tuncay E, Zeydanli E, Aydemir-Koksoy A, Turan B (2009) Antioxidants but not doxycycline treatments restore depressed beta-adrenergic responses of the heart in diabetic rats. CardiovascToxicol 9(1):21–29
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献